DYNEX CAPITAL INC (DX)

US26817Q8868 - REIT

11.66  -0.23 (-1.93%)

After market: 11.72 +0.06 (+0.51%)

Fundamental Rating

2

Taking everything into account, DX scores 2 out of 10 in our fundamental rating. DX was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. Both the profitability and financial health of DX have multiple concerns. While showing a medium growth rate, DX is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

DX had negative earnings in the past year.
In the past year DX had a positive cash flow from operations.
In multiple years DX reported negative net income over the last 5 years.
In the past 5 years DX always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -0.79%, DX is not doing good in the industry: 76.56% of the companies in the same industry are doing better.
With a Return On Equity value of -5.75%, DX is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.79%
ROE -5.75%
ROIC N/A
ROA(3y)2.01%
ROA(5y)1.63%
ROE(3y)8.41%
ROE(5y)4.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DX has been increased compared to 5 years ago.
DX has a worse debt/assets ratio than last year.

2.2 Solvency

DX has an Altman-Z score of -1.11. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
DX has a Altman-Z score of -1.11. This is amonst the worse of the industry: DX underperforms 96.88% of its industry peers.
The Debt to FCF ratio of DX is 87.25, which is on the high side as it means it would take DX, 87.25 years of fcf income to pay off all of its debts.
DX has a Debt to FCF ratio (87.25) which is comparable to the rest of the industry.
A Debt/Equity ratio of 6.23 is on the high side and indicates that DX has dependencies on debt financing.
DX has a Debt to Equity ratio of 6.23. This is amonst the worse of the industry: DX underperforms 82.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.23
Debt/FCF 87.25
Altman-Z -1.11
ROIC/WACCN/A
WACC5.36%

2.3 Liquidity

A Current Ratio of 0.03 indicates that DX may have some problems paying its short term obligations.
With a Current ratio value of 0.03, DX is not doing good in the industry: 85.94% of the companies in the same industry are doing better.
DX has a Quick Ratio of 0.03. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DX (0.03) is worse than 85.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03

6

3. Growth

3.1 Past

DX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -185.59%.
The Revenue has grown by 122.64% in the past year. This is a very strong growth!
Measured over the past years, DX shows a small growth in Revenue. The Revenue has been growing by 3.79% on average per year.
EPS 1Y (TTM)-185.59%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-900%
Revenue 1Y (TTM)122.64%
Revenue growth 3Y11.17%
Revenue growth 5Y3.79%
Revenue growth Q2Q328.05%

3.2 Future

DX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.46% yearly.
DX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 128.69% yearly.
EPS Next Y86.99%
EPS Next 2Y64.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year311.48%
Revenue Next 2Y128.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

DX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

DX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.08
EV/EBITDA N/A

4.3 Compensation for Growth

DX's earnings are expected to grow with 64.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.46%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.12%, DX is a good candidate for dividend investing.
DX's Dividend Yield is comparable with the industry average which is at 13.26.
Compared to an average S&P500 Dividend Yield of 2.44, DX pays a better dividend.
Industry RankSector Rank
Dividend Yield 13.12%

5.2 History

The dividend of DX decreases each year by -8.86%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
DX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-8.86%
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

DX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-185.97%
EPS Next 2Y64.46%
EPS Next 3YN/A

DYNEX CAPITAL INC

NYSE:DX (4/25/2024, 7:04:00 PM)

After market: 11.72 +0.06 (+0.51%)

11.66

-0.23 (-1.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap689.46M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 13.12%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.79%
ROE -5.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 6.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-185.59%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y86.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)122.64%
Revenue growth 3Y11.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y